For more than 30 years, the iwCLL has focused on bringing together international leaders in the understanding and treatment of chronic lymphocytic leukaemia (CLL).

We believe the XVII iwCLL conference will be no exception.

The 2017 assembly will review the state-of the-art and present exciting new concepts emerging from clinic-based and laboratory-based research about the pathobiology and treatment of this still incurable disease.

This information will be organised around the development, progression, and evolution of CLL.

As always, the iwCLL program will provide presenters a forum to share critical updates while providing attendees an opportunity to actively engage presenters, make important connections, gain insight into the latest treatment strategies, and leave inspired to continue advancing the care for patients with CLL.